These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 3905734)

  • 1. Cephabacin M1-6, new 7-methoxycephem antibiotics of bacterial origin. I. A producing organism, fermentation, biological activities, and mode of action.
    Nozaki Y; Katayama N; Tsubotani S; Ono H; Okazaki H
    J Antibiot (Tokyo); 1985 Sep; 38(9):1141-51. PubMed ID: 3905734
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cephabacins, new cephem antibiotics of bacterial origin. IV. Antibacterial activities, stability to beta-lactamases and mode of action.
    Nozaki Y; Okonogi K; Katayama N; Ono H; Harada S; Kondo M; Okazaki H
    J Antibiot (Tokyo); 1984 Dec; 37(12):1555-65. PubMed ID: 6335505
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Formadicins, new monocyclic beta-lactam antibiotics of bacterial origin. I. Taxonomy, fermentation and biological activities.
    Katayama N; Nozaki Y; Okonogi K; Ono H; Harada S; Okazaki H
    J Antibiot (Tokyo); 1985 Sep; 38(9):1117-27. PubMed ID: 3934120
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mode of action of beta-lactam antibiotics.
    Tipper DJ
    Pharmacol Ther; 1985; 27(1):1-35. PubMed ID: 3889939
    [No Abstract]   [Full Text] [Related]  

  • 5. Cephabacin M1-6, new 7-methoxycephem antibiotics of bacterial origin. II. Isolation, characterization and structural determination.
    Tsubotani S; Hida T; Ono H; Harada S
    J Antibiot (Tokyo); 1985 Sep; 38(9):1152-65. PubMed ID: 4066500
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro antibacterial activity of KP-736, a new cephem antibiotic.
    Maejima T; Inoue M; Mitsuhashi S
    Antimicrob Agents Chemother; 1991 Jan; 35(1):104-10. PubMed ID: 2014964
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SQ 26,180, a novel monobactam. I Taxonomy, fermentation and biological properties.
    Wells JS; Trejo WH; Principe PA; Bush K; Georgopapadakou N; Bonner DP; Sykes RB
    J Antibiot (Tokyo); 1982 Feb; 35(2):184-8. PubMed ID: 6978877
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lactivicin, a naturally occurring non-beta-lactam antibiotic having beta-lactam-like action: biological activities and mode of action.
    Nozaki Y; Katayama N; Harada S; Ono H; Okazaki H
    J Antibiot (Tokyo); 1989 Jan; 42(1):84-93. PubMed ID: 2493440
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Penem derivatives: beta-lactamase stability and affinity for penicillin-binding proteins in Escherichia coli.
    Ohya S; Utsui Y; Sugawara S; Yamazaki M
    Antimicrob Agents Chemother; 1982 Mar; 21(3):492-7. PubMed ID: 7049076
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [In vitro antibacterial activity of a new parenteral penem, sulopenem].
    Yoshida T; Tateda E; Hiramatsu K; Yokota T
    Jpn J Antibiot; 1996 Apr; 49(4):324-37. PubMed ID: 8786624
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Penicillin-binding proteins and beta-lactamases: their effects on the use of cephalosporins and other new beta-lactams.
    Neu HC
    Curr Clin Top Infect Dis; 1987; 8():37-61. PubMed ID: 3077281
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ways to overcome cephalosporinase-mediated beta-lactam resistance in Enterobacter cloacae.
    Then RL; Angehrn P
    Chemioterapia; 1985 Feb; 4(1):83-9. PubMed ID: 3872727
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of resistance to beta-lactam antibiotics with special reference to third-generation cephalosporins.
    Collatz E; Gutmann L; Williamson R; Acar JF
    J Antimicrob Chemother; 1984 Sep; 14 Suppl B():13-21. PubMed ID: 6334073
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PBP binding and periplasmic concentration as determinants of the antibacterial activities of three new oral cephalosporins in Escherichia coli.
    Cornaglia G; Ligozzi M; Bauernfeind A; Satta G; Fontana R
    New Microbiol; 1994 Jul; 17(3):203-10. PubMed ID: 7968655
    [TBL] [Abstract][Full Text] [Related]  

  • 15. RU 29 246, the active compound of the cephalosporin-prodrug-ester HR 916. II. Stability to beta-lactamases and affinity for penicillin-binding proteins.
    Markus A; Klesel N; Wollmann T; Isert D; Limbert M; Schrinner E; Seibert G; Bauernfeind A; Jungwirth R; Wilhelm R
    J Antibiot (Tokyo); 1992 Apr; 45(4):521-6. PubMed ID: 1592684
    [TBL] [Abstract][Full Text] [Related]  

  • 16. C-19393 S2 and H2, new carbapenem antibiotics. III. Mode of action.
    Nozaki Y; Kawashima F; Imada A
    J Antibiot (Tokyo); 1981 Feb; 34(2):206-11. PubMed ID: 7028708
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro antibacterial activity of FK041, a new orally active cephalosporin.
    Watanabe Y; Hatano K; Matsumoto Y; Tawara S; Yamamoto H; Kawabata K; Takasugi H; Matsumoto F; Kuwahara S
    J Antibiot (Tokyo); 1999 Jul; 52(7):649-59. PubMed ID: 10513845
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Penicillin-binding proteins and peptidoglycan peptide-interacting proteins.
    Rodríguez-Tébar A; Vázquez D
    Microbiol Sci; 1984 Dec; 1(9):211-4. PubMed ID: 6444131
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Studies on penem antibiotics. II. In vitro activity of SUN5555, a new oral penem.
    Nishino T; Maeda Y; Ohtsu E; Koizuka S; Nishihara T; Adachi H; Okamoto K; Ishiguro M
    J Antibiot (Tokyo); 1989 Jun; 42(6):977-88. PubMed ID: 2661512
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differences between ceftizoxime and its stereoisomer in antibacterial activity and affinity for penicillin-binding proteins.
    Shigi Y; Kojo H; Wakasugi M; Nishida M
    Antimicrob Agents Chemother; 1981 Mar; 19(3):393-6. PubMed ID: 7018389
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.